Sign up

IcoSema Versus Glargine

Clinical caseEndocrinology2 min
IcoSema Versus Glargine

An insulin-naive adult with type 2 diabetes has HbA1c of at least 8.0% despite oral glucose-lowering medications. Treatment intensification with injectable therapy is being considered.

What does the evidence from COMBINE 4 support for a patient like this?